IDH1R132H-specific peptide vaccine PEPIDH1M

{
  "id": "MLC-T-ONC-014311",
  "term": "IDH1R132H-specific peptide vaccine PEPIDH1M",
  "field": "Oncology and biomedicine",
  "definition": "A peptide vaccine consisting of a peptide derived from isocitrate dehydrogenase 1 (IDH1) containing the point mutation R132H (IDH1R132H), with potential antineoplastic activity. Intradermal vaccination with the IDH1R132H-specific peptide vaccine PEPIDH1M may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the IDH1R132H protein. The IDH1 point mutation of amino acid residue 132 is highly expressed in gliomas and is associated with increased production of the oncometabolite R-2-hydroxyglutarate (2HG).",
  "synonyms": [
    "PEPIDH1M vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/idh1r132h-specific-peptide-vaccine-pepidh1m/"
}